Optimization of the Targeted Anticancer Therapies
Recruiting
N/A
Interventional Study
Cancer
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
At a Glance
- Age
- 18 and older
- Sex
- Any
- Study type
- Interventional
- Purpose
- Other
- Participants needed
- 500 (estimated)
- Sponsor
- Centre Hospitalier Universitaire Vaudois · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
The study includes an observational pharmacokinetic study and an interventional medication adherence study. The purpose of this study is 1) to describe the concentration-time profiles of targeted anticancer drugs and to characterize the concentration-effect/toxicity relationships in the target population of patients (observational study) and 2) to characterize patterns of adherence to oral targete…
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* Cancer patients to whom a targeted anticancer therapy is prescribed
Exclusion Criteria:
* Patients incapable of judgment or participants under tutelage
Contacts